These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29387314)

  • 21. Community-based sero-prevalence of hepatitis B and C infections in South Omo Zone, Southern Ethiopia.
    Woldegiorgis AE; Erku W; Medhin G; Berhe N; Legesse M
    PLoS One; 2019; 14(12):e0226890. PubMed ID: 31887192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seroprevalence, genotypic distribution and potential risk factors of hepatitis B and C virus infections among adults in Siem Reap, Cambodia.
    Yamada H; Fujimoto M; Svay S; Lim O; Hok S; Goto N; Ohisa M; Akita T; Matsuo J; Do SH; Katayama K; Miyakawa Y; Tanaka J
    Hepatol Res; 2015 Apr; 45(4):480-7. PubMed ID: 24905888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Co-infection of human immunodeficiency virus, hepatitis C and hepatitis B virus among injection drug users in Drop in centers.
    Javadi A; Ataei B; Kassaian N; Nokhodian Z; Yaran M
    J Res Med Sci; 2014 Mar; 19(Suppl 1):S17-21. PubMed ID: 25002888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
    Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
    Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiological Aspects of Hepatitis B and C and Human Immunodeficiency Viruses Among Hemodialysis Patients in Mazandaran Province, Iran.
    Hasanjani Roushan MR; Farokhtabar S; Bayani M; Siadati S
    Nephrourol Mon; 2016 May; 8(3):e37878. PubMed ID: 27570757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology update for hepatitis C virus and hepatitis B virus in end-stage renal disease in France.
    Isnard Bagnis C; Couchoud C; Bowens M; Sarraj A; Deray G; Tourret J; Cacoub P; Tezenas du Montcel S
    Liver Int; 2017 Jun; 37(6):820-826. PubMed ID: 28107607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High prevalences of hepatitis B and C virus infections among adults living in Binh Thuan province, Vietnam.
    Do SH; Yamada H; Fujimoto M; Ohisa M; Matsuo J; Akita T; Katayama K; Van Nguyen N; Miyakawa Y; Tanaka J
    Hepatol Res; 2015 Mar; 45(3):259-68. PubMed ID: 24799322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment outcomes of HIV patients with hepatitis B and C virus co-infections in Southwest China: an observational cohort study.
    Jia J; Zhu Q; Deng L; Lan G; Johnson A; Chen H; Shen Z; Li J; Xing H; Ruan Y; Li J; Lu H; Vermund SH; Zhu J; Qian HZ
    Infect Dis Poverty; 2022 Jan; 11(1):7. PubMed ID: 34986877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study.
    Amini S; Mahmoodi MF; Andalibi S; Solati AA
    J Trop Med Hyg; 1993 Oct; 96(5):277-87. PubMed ID: 8411302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of hepatitis B surface antigen and HCV antibodies in hepatocellular carcinoma cases in Karachi, Pakistan.
    Abdul Mujeeb S; Jamal Q; Khanani R; Iqbal N; Kaher S
    Trop Doct; 1997 Jan; 27(1):45-6. PubMed ID: 9030022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends and epidemiological analysis of hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and human T-cell lymphotropic virus among Iranian blood donors: strategies for improving blood safety.
    Omidkhoda A; Razi B; Arabkhazaeli A; Amini Kafi-Abad S
    BMC Infect Dis; 2020 Oct; 20(1):736. PubMed ID: 33028232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A seroepidemiological survey of the effect of hepatitis B vaccine and hepatitis B and C virus infections among elementary school students in Siem Reap province, Cambodia.
    Fujimoto M; Chuon C; Nagashima S; Yamamoto C; Ko K; Svay S; Hok S; Lim O; Ohisa M; Akita T; Katayama K; Matsuo J; Takahashi K; Tanaka J
    Hepatol Res; 2018 Feb; 48(3):E172-E182. PubMed ID: 28753243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS).
    Glynn SA; Kleinman SH; Schreiber GB; Busch MP; Wright DJ; Smith JW; Nass CC; Williams AE
    JAMA; 2000 Jul; 284(2):229-35. PubMed ID: 10889598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal trends in hepatitis B and C infection in family blood donors from interior Sindh, Pakistan.
    Mujeeb SA; Pearce MS
    BMC Infect Dis; 2008 Apr; 8():43. PubMed ID: 18402660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B, C, and D virus infection showing distinct patterns between injection drug users and the general population.
    Chen F; Zhang J; Guo F; Wen B; Luo S; Yuan D; Lin Y; Ou W; Tang P; Dai G; Li F; Liu W; Qu X
    J Gastroenterol Hepatol; 2017 Feb; 32(2):515-520. PubMed ID: 27248508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Investigation of hepatitis B and hepatitis C virus infections by serological and molecular methods in hemodialysis patients].
    Dağlar D; Ergani A; Demirbakan H; Ozhak Baysan B; Ongüt G; Koçak H; Oğünç D; Akbaş H; Yıldırım B; Colak D
    Mikrobiyol Bul; 2014 Jan; 48(1):143-50. PubMed ID: 24506725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Performance characteristics and results of a large-scale screening program for viral hepatitis and risk factors associated with exposure to viral hepatitis B and C: results of the National Hepatitis Screening Survey. National Hepatitis Surveillance Group.
    Kaur S; Rybicki L; Bacon BR; Gollan JL; Rustgi VK; Carey WD
    Hepatology; 1996 Nov; 24(5):979-86. PubMed ID: 8903363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B in Poland in 2013.
    Piwowarow K; Stępień M
    Przegl Epidemiol; 2015; 69(2):251-6, 371-4. PubMed ID: 26233082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatocellular carcinoma in Taiwan.
    Chen DS
    Hepatol Res; 2007 Sep; 37 Suppl 2():S101-5. PubMed ID: 17877468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency distribution and risk factors of hepatitis B virus and hepatitis C virus infections among thalassemia patients: a regional study.
    Shah T; Hussain W; Ali N; Sardar S; Ishaq M; Ur Rahman M; Ding L; Qayyum S; Khan I
    Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):248-252. PubMed ID: 30358571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.